Literature DB >> 19368902

The origin of methylglyoxal in New Zealand manuka (Leptospermum scoparium) honey.

Christopher J Adams1, Merilyn Manley-Harris, Peter C Molan.   

Abstract

Methylglyoxal in New Zealand manuka honey has been shown to originate from dihydroxyacetone, which is present in the nectar of manuka flowers in varying amounts. Manuka honey, which was freshly produced by bees, contained low levels of methylglyoxal and high levels of dihydroxyacetone. Storage of these honeys at 37 degrees C led to a decrease in the dihydroxyacetone content and a related increase in methylglyoxal. Addition of dihydroxyacetone to clover honey followed by incubation resulted in methylglyoxal levels similar to those found in manuka honey. Nectar washed from manuka flowers contained high levels of dihydroxyacetone and no detectable methylglyoxal.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19368902     DOI: 10.1016/j.carres.2009.03.020

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  46 in total

1.  A Critical Review and Perspective of Honey in Tissue Engineering and Clinical Wound Healing.

Authors:  Katherine R Hixon; Robert C Klein; Christopher T Eberlin; Houston R Linder; William J Ona; Hugo Gonzalez; Scott A Sell
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-07-25       Impact factor: 4.730

Review 2.  Dissecting the Antimicrobial Composition of Honey.

Authors:  Victoria C Nolan; James Harrison; Jonathan A G Cox
Journal:  Antibiotics (Basel)       Date:  2019-12-05

3.  Genome-wide patterns of genetic diversity, population structure and demographic history in mānuka (Leptospermum scoparium) growing on indigenous Māori land.

Authors:  Emily Koot; Elise Arnst; Melissa Taane; Kelsey Goldsmith; Amali Thrimawithana; Kiri Reihana; Santiago C González-Martínez; Victor Goldsmith; Gary Houliston; David Chagné
Journal:  Hortic Res       Date:  2022-01-18       Impact factor: 6.793

4.  Two major medicinal honeys have different mechanisms of bactericidal activity.

Authors:  Paulus H S Kwakman; Anje A Te Velde; Leonie de Boer; Christina M J E Vandenbroucke-Grauls; Sebastian A J Zaat
Journal:  PLoS One       Date:  2011-03-04       Impact factor: 3.240

5.  Manuka honey-impregnated dressings in the treatment of neuropathic diabetic foot ulcers.

Authors:  Alexandros V Kamaratos; Konstantinos N Tzirogiannis; Stella A Iraklianou; Georgios I Panoutsopoulos; Ilias E Kanellos; Andreas I Melidonis
Journal:  Int Wound J       Date:  2012-09-18       Impact factor: 3.315

6.  The intracellular effects of manuka honey on Staphylococcus aureus.

Authors:  A F Henriques; R E Jenkins; N F Burton; R A Cooper
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-10-08       Impact factor: 3.267

7.  A pilot study investigating lactic acid bacterial symbionts from the honeybee in inhibiting human chronic wound pathogens.

Authors:  Éile Butler; Rut F Oien; Christina Lindholm; Tobias C Olofsson; Bo Nilson; Alejandra Vásquez
Journal:  Int Wound J       Date:  2014-09-08       Impact factor: 3.315

8.  The Association Between Glucose Exposure and the Risk of Peritonitis in Peritoneal Dialysis Patients.

Authors:  Anouk T N van Diepen; Sadie van Esch; Dirk G Struijk; Raymond T Krediet
Journal:  Perit Dial Int       Date:  2016-04-04       Impact factor: 1.756

9.  The effect of New Zealand kanuka, manuka and clover honeys on bacterial growth dynamics and cellular morphology varies according to the species.

Authors:  Jing Lu; Dee A Carter; Lynne Turnbull; Douglas Rosendale; Duncan Hedderley; Jonathan Stephens; Swapna Gannabathula; Gregor Steinhorn; Ralf C Schlothauer; Cynthia B Whitchurch; Elizabeth J Harry
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

10.  Synergism between Medihoney and rifampicin against methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Patrick Müller; Dagmar G Alber; Lynne Turnbull; Ralf C Schlothauer; Dee A Carter; Cynthia B Whitchurch; Elizabeth J Harry
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.